Skip to content

Treatment of Langerhans cell histiocytosis with pamidronate

by R.P. Farran, Eldon Zaretski, R.M. Egeler
Journal of pediatric hematology/oncology ()
Get full text at journal

Abstract

A 14-year-old boy with longstanding multisystem Langerhans cell histiocytosis (LCH) had multifocal bone pain unresponsive to chemotherapy, corticosteroids, anti-inflammatories, and narcotic analgesics. He responded to two cycles of intravenous pamidronate, each 90 mg per day on three consecutive days. Two subsequent episodes of deterioration also responded to treatment. The pathophysiology of his bone pain and the likely mechanisms of biphosphonate action are discussed, with emphasis on the molecular and cellular basis of LCH.

Cite this document (BETA)

Readership Statistics

4 Readers on Mendeley
by Discipline
 
75% Medicine and Dentistry
 
25% Agricultural and Biological Sciences
by Academic Status
 
50% Student > Bachelor
 
25% Professor
 
25% Student > Postgraduate

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in